Pfisterer ME - Search Results

1

Management of stable coronary artery disease.

Pfisterer ME, Zellweger MJ, Gersh BJ. Pfisterer ME, et al. Lancet. 2010 Feb 27;375(9716):763-72. doi: 10.1016/S0140-6736(10)60168-7. Lancet. 2010. PMID: 20189028 Review.

2

Gate-keeper to coronary angiography: comparison of exercise testing, myocardial perfusion SPECT and individually tailored approach for risk stratification.

Muzzarelli S, Pfisterer ME, Müller-Brand J, Zellweger MJ. Muzzarelli S, et al. Among authors: pfisterer me. Int J Cardiovasc Imaging. 2010 Dec;26(8):871-9. doi: 10.1007/s10554-010-9627-y. Epub 2010 Apr 22. Int J Cardiovasc Imaging. 2010. PMID: 20411429

3

Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting.

Zellweger MJ, Weinbacher M, Zutter AW, Jeger RV, Mueller-Brand J, Kaiser C, Buser PT, Pfisterer ME. Zellweger MJ, et al. Among authors: pfisterer me. J Am Coll Cardiol. 2003 Jul 2;42(1):33-40. doi: 10.1016/s0735-1097(03)00557-6. J Am Coll Cardiol. 2003. PMID: 12849656 Free article.

4

Coronary artery disease and depression.

Zellweger MJ, Osterwalder RH, Langewitz W, Pfisterer ME. Zellweger MJ, et al. Among authors: pfisterer me. Eur Heart J. 2004 Jan;25(1):3-9. doi: 10.1016/j.ehj.2003.09.009. Eur Heart J. 2004. PMID: 14683736 Review.

5

Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery disease.

Bonetti PO, Kaiser C, Zellweger MJ, Grize L, Erne P, Schoenenberger RA, Pfisterer ME; TIME Investigators. Bonetti PO, et al. Among authors: pfisterer me. J Cardiovasc Pharmacol Ther. 2005 Mar;10(1):29-37. doi: 10.1177/107424840501000104. J Cardiovasc Pharmacol Ther. 2005. PMID: 15821836

6

Influence of revascularization on long-term outcome in patients > or =75 years of age with diabetes mellitus and angina pectoris.

Jeger RV, Bonetti PO, Zellweger MJ, Tobler D, Kaiser CA, Osswald S, Buser PT, Pfisterer ME. Jeger RV, et al. Among authors: pfisterer me. Am J Cardiol. 2005 Jul 15;96(2):193-8. doi: 10.1016/j.amjcard.2005.03.042. Am J Cardiol. 2005. PMID: 16018840 Clinical Trial.

7

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET).

Kaiser C, Brunner-La Rocca HP, Buser PT, Bonetti PO, Osswald S, Linka A, Bernheim A, Zutter A, Zellweger M, Grize L, Pfisterer ME; BASKET Investigators. Kaiser C, et al. Among authors: pfisterer me. Lancet. 2005 Sep 10-16;366(9489):921-9. doi: 10.1016/S0140-6736(05)67221-2. Lancet. 2005. PMID: 16154019 Clinical Trial.

8

Therapeutic strategies in patients with chronic stable coronary artery disease.

Zellweger MJ, Pfisterer ME. Zellweger MJ, et al. Among authors: pfisterer me. Cardiovasc Ther. 2011 Dec;29(6):e23-30. doi: 10.1111/j.1755-5922.2010.00164.x. Epub 2010 May 13. Cardiovasc Ther. 2011. PMID: 20491783 Free article. Review.

9

A new memetic pattern based algorithm to diagnose/exclude coronary artery disease.

Zellweger MJ, Brinkert M, Bucher U, Tsirkin A, Ruff P, Pfisterer ME. Zellweger MJ, et al. Among authors: pfisterer me. Int J Cardiol. 2014 Jun 1;174(1):184-6. doi: 10.1016/j.ijcard.2014.03.184. Epub 2014 Apr 6. Int J Cardiol. 2014. PMID: 24750720 No abstract available.

10

Elevated troponin levels in absence of coronary artery disease after supraventricular tachycardia.

Zellweger MJ, Schaer BA, Cron TA, Pfisterer ME, Osswald S. Zellweger MJ, et al. Among authors: pfisterer me. Swiss Med Wkly. 2003 Aug 9;133(31-32):439-41. doi: 10.4414/smw.2003.10288. Swiss Med Wkly. 2003. PMID: 14562187 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters